| 摘要 |
The invention relates to the identification and selection of novel RNA biomarker combinations which are differentially expressed in individuals with mild osteoarthritis as compared with individuals without osteoarthritis. The invention is a method of diagnosing or detecting osteoarthritis (OA) by determining the level of specific RNA products, e.g. the RNA product of IL13RA1, in a test, e.g. blood or cartilage, sample. |
